222 followers
RT @FrontImmunol: New Research: Current Advances in PD-1/PD-L1 Blockade in Recurrent Epithelial Ovarian Cancer: Immunotherapies have revolu…
RT @FrontImmunol: New Research: Current Advances in PD-1/PD-L1 Blockade in Recurrent Epithelial Ovarian Cancer: Immunotherapies have revolu…
New Research: Current Advances in PD-1/PD-L1 Blockade in Recurrent Epithelial Ovarian Cancer: Immunotherapies have revolutionized the treatment of a variety of cancers. Epithelial ovarian cancer is the most lethal gynecologic malignancy, and… https://t.co/